SCHEMBL23713541

SCHEMBL23713541

C=COc1ccc2cc(-c3ccccc3C(F)(F)C(F)(F)F)c(=O)oc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.44
NPC1 O15118 9/20 0.44
KDM4E B2RXH2 10/20 0.41
GLA P06280 5/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
MAOB P27338 3/20 0.41
MAOA P21397 1/20 0.41
HPGD P15428 8/20 0.40
ALDH1A1 P00352 7/20 0.40
GAA P10253 6/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
MAPT P10636 3/20 0.40
MIF P14174 2/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KLK7 P49862 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18583701 0.86 NPC1 (0.62) RAB9ANPC1KDM4EGLAMAOB
SCHEMBL21524260 0.84 NPC1 (0.47) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL23713542 0.83 RAB9A (0.51) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL23713534 0.83 MIF (0.46) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL18535566 0.83 RAB9A (0.45) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL18535495 0.82 GLA (0.65) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL18535716 0.80 MIF (0.62) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL18535609 0.79 KLK7 (0.40) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL27105690 0.77 KLK7 (0.41) RAB9ANPC1KDM4EGLAKMT2A
SCHEMBL18535568 0.77 RAB9A (0.40) RAB9ANPC1KDM4EGLAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A RAB9A 930/4885NPC1 2482/4885KDM4E 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.